Krzysztof Laudanski1. 1. Department of Anesthesiology and Critical Care, Department of Neurology, Leonard Davis Institute of Healthcare Economics, University of Pennsylvania, Philadelphia, PA 19194, USA.
Abstract
(1) Background. Repetitive animal studies that have disappointed upon translation into clinical therapies have led to an increased appreciation of humanized mice as a remedy to the shortcomings of rodent-based models. However, their limitations have to be understood in depth. (2) Methods. This is a narrative, comprehensive review of humanized mice and sepsis literature to understand the model's benefits and shortcomings. (3) Results: Studies involving humanized models of sepsis include bacterial, viral, and protozoan etiology. Humanized mice provided several unique insights into the etiology and natural history of sepsis and are particularly useful in studying Ebola, and certain viral and protozoan infections. However, studies are relatively sparse and based on several different models of sepsis and humanized animals. (4) Conclusions. The utilization of humanized mice as a model for sepsis presents complex limitations that, once surpassed, hold some potential for the advancement of sepsis etiology and treatment.
(1) Background. Repetitive animal studies that have disappointed upon translation into clinical therapies have led to an increased appreciation of humanized mice as a remedy to the shortcomings of rodent-based models. However, their limitations have to be understood in depth. (2) Methods. This is a narrative, comprehensive review of humanized mice and sepsis literature to understand the model's benefits and shortcomings. (3) Results: Studies involving humanized models of sepsis include bacterial, viral, and protozoan etiology. Humanized mice provided several unique insights into the etiology and natural history of sepsis and are particularly useful in studying Ebola, and certain viral and protozoan infections. However, studies are relatively sparse and based on several different models of sepsis and humanized animals. (4) Conclusions. The utilization of humanized mice as a model for sepsis presents complex limitations that, once surpassed, hold some potential for the advancement of sepsis etiology and treatment.
Authors: E R Jarman; K Perschke; E Montermann; U Herz; H Renz; J Knop; A B Reske-Kunz Journal: J Allergy Clin Immunol Date: 2000-05 Impact factor: 10.793
Authors: Patrick Scheiermann; Sandra Hoegl; Marc Revermann; Devan Ahluwalia; Johannes Zander; Kim A Boost; Thach Nguyen; Bernhard Zwissler; Heiko Muhl; Christian Hofstetter Journal: J Surg Res Date: 2008-03-18 Impact factor: 2.192
Authors: Ashley M Vaughan; Richard S Pinapati; Ian H Cheeseman; Nelly Camargo; Matthew Fishbaugher; Lisa A Checkley; Shalini Nair; Carolyn A Hutyra; François H Nosten; Timothy J C Anderson; Michael T Ferdig; Stefan H I Kappe Journal: Nat Methods Date: 2015-06-01 Impact factor: 28.547
Authors: Wathsala Wijayalath; Sai Majji; Eileen F Villasante; Teodor D Brumeanu; Thomas L Richie; Sofia Casares Journal: Malar J Date: 2014-09-30 Impact factor: 2.979
Authors: Melisa Gualdrón-López; Erika L Flannery; Niwat Kangwanrangsan; Vorada Chuenchob; Dietmar Fernandez-Orth; Joan Segui-Barber; Felix Royo; Juan M Falcón-Pérez; Carmen Fernandez-Becerra; Marcus V G Lacerda; Stefan H I Kappe; Jetsumon Sattabongkot; Juan R Gonzalez; Sebastian A Mikolajczak; Hernando A Del Portillo Journal: Front Microbiol Date: 2018-06-25 Impact factor: 5.640
Authors: Tomasz Skirecki; Susanne Drechsler; Grazyna Hoser; Mohammad Jafarmadar; Katarzyna Siennicka; Zygmunt Pojda; Jerzy Kawiak; Marcin F Osuchowski Journal: Front Immunol Date: 2019-06-26 Impact factor: 7.561